The Thorough QT Study - Do We Need More of the Same?
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Diemberger I, Raschi E, Trifiro G Clin Drug Investig. 2017; 37(10):985-988.
PMID: 28831689 DOI: 10.1007/s40261-017-0563-7.
The thorough QT study - do we need more of the same?.
Loke Y Br J Clin Pharmacol. 2015; 81(3):400-1.
PMID: 26692294 PMC: 4767199. DOI: 10.1111/bcp.12871.
References
1.
Loke Y
. The thorough QT study - do we need more of the same?. Br J Clin Pharmacol. 2015; 81(3):400-1.
PMC: 4767199.
DOI: 10.1111/bcp.12871.
View
2.
Darpo B
. The thorough QT/QTc study 4 years after the implementation of the ICH E14 guidance. Br J Pharmacol. 2009; 159(1):49-57.
PMC: 2823351.
DOI: 10.1111/j.1476-5381.2009.00487.x.
View
3.
Darpo B, Garnett C, Keirns J, Stockbridge N
. Implications of the IQ-CSRC Prospective Study: Time to Revise ICH E14. Drug Saf. 2015; 38(9):773-80.
DOI: 10.1007/s40264-015-0325-5.
View
4.
Barbour A, Magee M, Shaddinger B, Arya N, Tombs L, Tao W
. Utility of concentration-effect modeling and simulation in a thorough QT study of losmapimod. J Clin Pharmacol. 2015; 55(6):661-70.
DOI: 10.1002/jcph.465.
View
5.
Bouvy J, Koopmanschap M, Shah R, Schellekens H
. The cost-effectiveness of drug regulation: the example of thorough QT/QTc studies. Clin Pharmacol Ther. 2011; 91(2):281-8.
DOI: 10.1038/clpt.2011.224.
View